Quaker Houghton competitors

Mr. Dempsey has been the President and Chief Executive Officer of the Company since March 1, 2013. He joined the Company in 2000 as President, Barnes Aerospace, Windsor Airmotive. He was appointed Vice President, Operations, Barnes Aerospace in 2003; President, Barnes Aerospace in 2004; President, Barnes Distribution in 2007; and Vice President, Barnes Group Inc. and President, Logistics and Manufacturing Services in 2008. He was named Senior Vice President and Chief Operating Officer in 2012. Prior to joining Barnes Group Inc., Mr. Dempsey held leadership positions at United Technologies’ Pratt and Whitney Division and the Interturbine Group of Companies. Mr. Dempsey serves on the Executive Committee and has been a director since 2013.

Max Mitchell is a Board Member at Crane Co, President/CEO at Crane Co, and Board Member at LENNOX INTERNATIONAL INC and is based in Weston, Connecticut. He has experience at Ford and Danaher and has worked as Pres:Fluid Handling at Crane Co, Senior VP:Global Operations at Pentair Tools Group Inc, and Exec VP/COO/Pres:Fluid at Crane Co. Max studied at Tulane University and Katz Graduate School of Business.

Ronald J. Kramer has been our Chairman since January 2018, Chief Executive Officer since April 2008 and a Director since 1993. From 2002 through March 2008, he was President and a Director of Wynn Resorts, Ltd. (NASDAQ:WYNN), a developer, owner and operator of destination casino resorts. From 1999 to 2001, Mr. Kramer was a Managing Director at Dresdner Kleinwort Wasserstein, an investment banking firm, and its predecessor Wasserstein Perella & Co.

C. Howard Nye has served as Chairman of the Board since 2014, as President of Martin Marietta since 2006 and as Chief Executive Officer and a Director since 2010. Mr. Nye previously served as Chief Operating Officer from 2006 to 2009. Prior to joining Martin Marietta in 2006, Mr. Nye served as Executive Vice President, Hanson Aggregates North America, a producer of aggregates for the construction industry. Mr. Nye received a bachelor's degree with honors from Duke University and a law degree from Wake Forest University. In addition to his educational, professional and executive roles, Mr. Nye has been a gubernatorial appointee to the North Carolina Mining Commission and is a past Chairman and Executive Committee member of the National Stone, Sand & Gravel Association (NSSGA). He currently serves as Vice Chairman of the American Road Transportation Builders Association (ARTBA). Mr. Nye also serves as a director of the United States Chamber of Commerce, the world's largest business organization representing the interests of more than 3 million businesses. He also is an independent director of CREE, Inc. (NASDAQ: CREE), a multinational manufacturer of semiconductor light-emitting diode materials and devices where he serves on both the Audit as well as the Nominating and Corporate Governance Committees. Mr. Nye has further served on numerous other state, community and charitable organizations including the Duke University Alumni Association Board, Wake Forest University School of Law Alumni Board, and as Vice Chairman of UNC Rex Healthcare, Inc.'s Board of Trustees.

Frank Bozich is a Board Member at OGE ENERGY CORP., Board Member at TRINSEO S.A., and President/CEO at TRINSEO S.A. and is based in Schenectady, New York. He has experience at Croda Adhesives Inc and has worked as Pres:Global Catalysts Division at BASF, GM Adhesives and Sealants at Rohm And Haas Co., and Group VP:Enterprise Technologies at Engelhard Corporation. Frank works or has worked as BOARD MEMBER at Capital Region Chamber of Commerce and TRUSTEE at Ellis Medicine Board of Trustees. He studied at University of Chicago between 1980 and 1982, Boston College between 1978 and 1980, and University of Illinois between 1982 and 1983.

Experience medical device CEO and Board member with proven experience in building result oriented teams, and leading cross cultural global organizations that accelerate revenue growth, improve commercial operations, (sales, clinical and marketing), enhance new product development and increase shareholder value.